Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for gastric cancer
Open Access
- 25 November 2015
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Cancer
- Vol. 15 (1), 1-8
- https://doi.org/10.1186/s12885-015-1943-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Enhancement Patterns of Gastric Carcinoma on Contrast-Enhanced Ultrasonography: Relationship with Clinicopathological FeaturesPLOS ONE, 2013
- A Gastric Calcifying Fibrous Pseudotumor Detected by Transabdominal Ultrasound after Oral Administration of an Echoic Cellulose-Based Gastrointestinal Ultrasound Contrast AgentUltraschall in der Medizin - European Journal of Ultrasound, 2013
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registryGastric Cancer, 2012
- Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesionsWorld Journal of Gastroenterology, 2012
- Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)Endoscopy, 2011
- Role of Low-Mechanical Index CEUS in the Differentiation between Low and High Grade Bladder Carcinoma: a Pilot StudyUltraschall in der Medizin - European Journal of Ultrasound, 2011
- Gastric Cancer Screening in Korea: Report on the National Cancer Screening Program in 2008Cancer Research and Treatment, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Incidence and risk factor of fundic gland polyp and hyperplastic polyp in long-term proton pump inhibitor therapy: a prospective study in JapanThe Esophagus, 2010
- Screening for gastric cancer in Asia: current evidence and practiceThe Lancet Oncology, 2008